2026 Medical Fee Schedule Revision Related Notifications Corrected, Facility Requirements Added for "Home-Based Cancer Treatment Electrical Field Therapy Management Fee" for Non-Small Cell Lung Cancer - GemMed

SUMMARY

Google News: According to reports on the medical fee schedule revision, it has been announced that "2026 Medical Fee Schedule Revision Related Notifications Corrected, Facility Requirements Added for “Home-Based Cancer Treatment Electrical Field Therapy Management Fee” for Non-". This information is relevant for the latest trends in the medical industry and can be used for management decisions by hospitals, clinics, and medical corporations.

📝 EDITOR'S NOTE — A Medical M&A Perspective

Regarding the medical fee schedule revision this time,[Home-Based Cancer Treatment Electrical Field Therapy Management Fee]The addition of facility requirements signifies the expansion of insurance coverage for new treatment options for non-small cell lung cancer patients. Within the broader trend of promoting home-based medical care, this suggests that advanced medical technologies may become more accessible for introduction in clinics and smaller hospitals.

From the perspective of Medical M&A and business succession,"Securing new revenue streams"と"Enhancing specialization"can be viewed from these two perspectives. In particular, to introduce and maintain advanced and specialized treatments like home-based cancer treatment electrical field therapy, certain capital investments and the securing of specialized personnel are essential. For individual medical institutions, meeting these requirements and continuing to implement them can pose a management burden.

Therefore, in the context of business succession and M&A,Pursuing economies of scaleやresource sharingbecomes a crucial point. For example, through mergers or collaborations with larger medical groups or medical institutions with similar specialized fields, it becomes easier to maintain facility standards, jointly purchase or utilize expensive medical equipment, and establish systems for dispatching specialists and training personnel. This allows management to capture new revenue opportunities while ensuring treatment quality and broadening future business succession options.

For medical institution managers facing issues with successors or management strategy,"Can our institution alone sustain this new treatment?" "Will it be worth the future investment burden?"it is an excellent opportunity to consider the potential for resource enhancement through group affiliation or M&A from these perspectives. Integrating system changes into management strategy leads to the establishment of a sustainable medical provision system.

News Highlights

Notifications regarding the 2026 medical fee schedule revision have been corrected, with the addition of facility requirements for implementing the “Home-Based Cancer Treatment Electrical Field Therapy Management Fee” for non-small cell lung cancer patients. This change may impact the popularization of advanced home-based cancer treatments and the operational strategies of medical institutions.

M&A Medical Editorial Department’s Perspective

The addition of facility requirements for the “Home-Based Cancer Treatment Electrical Field Therapy Management Fee” in this medical fee schedule revision serves as an opportunity for medical institutions, particularly clinics and hospitals focusing on cancer treatment, to consider new management strategies. Introducing or expanding this treatment method requires certain capital investments and securing specialized personnel. When independent handling is difficult, pursuing economies of scale through M&A can be a viable option. For example, by integrating multiple clinics, the burden of maintaining facility standards and capital investment can be distributed, enabling the provision of high-quality home-based treatment to a larger number of patients. Furthermore, by considering tax schemes such as transitioning to a specific medical corporation or social medical corporation, a path for business succession can be envisioned while receiving financial preferential treatment. This revision suggests a new approach to cancer treatment in regional healthcare and the potential for associated business restructuring.

Points Raised by This News

Pressure to review cancer treatment provision systems due to the clarification of facility requirements for the Home-Based Cancer Treatment Electrical Field Therapy Management Fee.
Impact of promoting home-based advanced treatments on capital investment and human resource development strategies for clinics and hospitals.
Possibility of maintaining facility standards and distributing capital investment burdens through M&A leveraging economies of scale.
Scope for considering business succession by utilizing tax schemes, including potential transition to specific medical corporations.

Practical Questions Arising from This News

If our clinic introduces or expands home-based cancer treatment electrical field therapy, what specific capital investments and staffing arrangements will be necessary?
To what extent will M&A with nearby medical institutions offering similar treatments contribute to maintaining facility standards and improving profitability?
What are the tax advantages and disadvantages when considering a transition to a specific medical corporation, etc., while maintaining and improving the quality of home-based treatment?

If You Feel “Should I Consult Too?”

For managers and successors who are unsure whether to introduce or expand home-based cancer treatment electrical field therapy at their own institution, or to collaborate/integrate with nearby medical institutions, in response to the addition of facility requirements for the Home-Based Cancer Treatment Electrical Field Therapy Management Fee in the latest medical fee schedule revision, the first step should be to calmly assess your institution’s current facilities, staffing, and alignment with future cancer treatment strategies. In particular, the trend towards home-based advanced treatments may make M&A for economies of scale or business succession utilizing tax schemes a viable option when independent handling is difficult. It is well worth considering consulting with experts for management decisions that look towards the future.

M&A Medical (CentralMedience Inc.) supports the business succession of medical corporations, hospitals, and clinics with a complete success fee system as an M&A support institution certified by the Small and Medium Enterprise Agency. Consultations are kept strictly confidential. Free consultation here

📌 Source (Primary Information)

2026 Medical Fee Schedule Revision Related Notifications Corrected, Facility Requirements Added for “Home-Based Cancer Treatment Electrical Field Therapy Management Fee” for Non

Source: Google News: Medical Fee Revision

Please see the original article for details

Regarding trends in medical institutions like this case,

we provide a detailed explanation of the 'Medical Succession Guide'

Read the Complete Guide →